Health investigation investment and the burden of disease because of B and C hepatitis;Financiación de la investigación sanitaria y carga de enfermedad por hepatitis B y C

Revista Espanola de Salud Publica

Volumn 83, Issue 4, 2009, Pages 587-588

  García Fulgueiras, Ana ^a,b   García Pina, Rocío ^a,b   García Ortúzar, Visitación ^a,b  

^a HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COST OF ILLNESS; ECONOMICS; HEPATITIS B; HEPATITIS C; HUMAN; MEDICAL RESEARCH; NOTE;

BIOMEDICAL RESEARCH; COST OF ILLNESS; HEPATITIS B; HEPATITIS C; HUMANS;

EID: 73949093330     PISSN: 11355727     EISSN: 16969820     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. Catalá López F, Á lvarez Martín E, Génova Maleras R, Morant Ginestar C. Relación en España entre la investigación sanitaria financiada por el sistema nacional de salud y la carga de enfermedad en la comunidad. Rev Esp Salud Pública. 2009;83:137-151
2. Bruguera M, Foros X. Hepatitis C en España. Med Clin (Barc). 2006;127:113-7.
3. García-Fulgueiras A, García-Pina R, Morant C, GArcía-Ortuzar V, Génova R, Á lvarez E. Hepatitis C and Hepatitis B-related mortality in Spain. Eur J Gastroenterol Hepatol 2009;21(8):895-901.
4. Mathers CD, Stein C, Ma Fat D, Rao Ch, Inoue M, Tomijima N et al. Global Burden of Disease 2000: version 2 methods and results. Global Programme on Evidence for Health Policy Discussion Paper No. 50. Gèneva:WHO, 2002. Disponible en: http://www.who.int/healthinfo/paper50.pdf
5. The global burden of hepatitis C working group. Global Burden of Disease for Hepatitis C. J Clin Pharmacol. 2004;44:20-29.
6. Muhlberger N, Schwarzer R, Lettmeier B, Sroczynski G, Zeuzem S, Siebert U. HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity and mortality. BMC Public Health. 2009;9:34. Disponible en: http://www.biomedcentral.com/1471-2458/9/34
7. Buti M, San Miguel R, Brosa M, Cabasés JM, Medina M, Casado MA et al. Estimating the impact of hepatitis C virus therapy on future liverrelated morbidity, mortality and costs related to chronic hepatitis C. J Hepatol. 2005;42:639-645
8. Idris BI, Brosa M, Richardus JH, Esteban R, Schalm W, Buti M. Estimating the future health burden of chronic hepatitis B and the impact of therapy in Spain. Eur J Gastroenterol Hepatol. 2008;20:320-326
9. García-Fulgueiras A, García-Pina R, Morant C, Fernandez N, García-Ortuzar V, Genova R, Alvarez E. Carga de enfermedad por virus de hepatitis C y B en España en el año 2000. Gac Sanit. 2007;21(Espec Congr):95